// company-profile
Scribe Therapeutics, Inc. Insider Trading
SCTXEvery SEC Form 4 insider trading filing for Scribe Therapeutics, Inc. (SCTX) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings13Insiders19
// api This Scribe Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
curl "https://api.form4api.com/v1/transactions?ticker=SCTX" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
Recent insider activity is bullish. Over the last 30 days, 21 insiders purchased shares (net $71.3M). Buying was led by Aghazadeh Behzad.
// 90-day insight
Over the last 90 days, Scribe Therapeutics, Inc. insiders bought $71.3M across 21 transactions with no open-market sales.
- Most active insider: AH Bio Fund II, L.P. with 5 transactions totaling $5.0M.
- Largest single purchase: $35.0M by Aghazadeh Behzad on Jul 24, 2026.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 28, 2026 | Aghazadeh Behzad | SCTX | Purchase | 7,905 | $18.25 | $144K |
| Jul 27, 2026 | AH Bio Fund II, L.P. | SCTX | C | 12,150,003 | $0.00 | $0K |
| Jul 27, 2026 | AH Bio Fund II, L.P. | SCTX | C | 4,131,344 | $0.00 | $0K |
| Jul 27, 2026 | Doudna Jennifer A | SCTX | C | 12,511 | — | — |
| Jul 27, 2026 | Doudna Jennifer A | SCTX | C | 74,088 | — | — |
30 more transactions hidden
Free account · No credit card required
Building something? Get API access →